Diagnostics giant cemented its leading role during the pandemic

Although the Covid-19 pandemic revolutionized the demand for diagnostics products, the players on the global market have maintained their respective positions. The biggest diagnostics companies have reaped the greatest rewards from the crisis, says the global CEO at Roche Diagnostics.
It's been full steam ahead for Roche Diagnostics during the pandemic. The company had its first product ready just a few days after the virus had been sequenced. | Photo: Roche / PR
It's been full steam ahead for Roche Diagnostics during the pandemic. The company had its first product ready just a few days after the virus had been sequenced. | Photo: Roche / PR
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN

As the Covid-19 pandemic spread rapidly across the globe, words like "PCR tests" and "antigen tests" became part of everyday vernacular, and the crucial importance of the diagnostics industry suddenly became frighteningly obvious to both citizens and politicians alike.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading